June 8, 2005 |
Justice Department lawyers Tuesday asked a federal judge for sweeping sanctions against the biggest tobacco companies, saying the government had proved a 50-year industry conspiracy to mislead the public with "half truths, deceptions and lies that continue to this day." But without explanation, government attorneys drastically reduced their most expensive demand, scaling back a proposed industry-funded smoking-cessation program from $130 billion to $10 billion.
June 3, 2005 |
Tropicana Products Inc. will stop claiming that its Healthy Heart orange juice will reduce the risk of heart disease and stroke, under a settlement reached with the Federal Trade Commission on Thursday. The FTC had alleged that Tropicana, a unit of PepsiCo Inc., misled consumers with claims that drinking two to three glasses a day of its Healthy Heart brand orange juice would produce dramatic effects on blood pressure and cholesterol.
March 15, 2005 |
Discount brokerage pioneer Charles Schwab Corp. sued the TD Waterhouse Group Inc. on Monday, alleging that its rival's advertisements falsely labeled Schwab as a high-priced firm with inferior service. The trade libel complaint filed in state court underscores Schwab's determination to reclaim its reputation as a bargain brokerage.
March 12, 2005 |
AstraZeneca has received its second warning in four months from the U.S. Food and Drug Administration over what the agency says are misleading claims in its ads for cholesterol-lowering medicine Crestor, the company said in New York. The latest letter said claims that Crestor lowers cholesterol better than Pfizer Inc.'s Lipitor were misleading because it cherry picked results from a study comparing the two medicines.
March 8, 2005 |
Blockbuster Inc. is in talks aimed at resolving an investigation by at least 37 states, including California, into whether the company has deceived customers with its recent "End of Late Fees" advertising campaign, people familiar with the matter said Monday. Blockbuster's television ad campaign, run in January, prompted a lawsuit by New Jersey's attorney general and then the probe by the states' attorneys general.
CALIFORNIA | LOCAL
January 19, 2005 |
An Orange County herbal supplement company has agreed to pay $3.58 million in fines to settle a case involving allegations that it misled consumers by promoting one of its products as a cure for cancer, AIDS and other diseases, authorities announced Tuesday.
January 13, 2005 |
Advertisements for the arthritis drug Celebrex were misleading and unsubstantiated, overstating the pain reliever's benefits and understating the risks, the Food and Drug Administration said. The agency asked for an immediate halt to all ads for Celebrex, which Pfizer Inc. did last month in advance of the agency's letter. A study in December found high doses of Celebrex were associated with an increased risk of heart attack.
December 25, 2004 |
Adolph Coors Co.'s Coors Brewing Co. is stopping advertisements on CBS television that claim its Aspen Edge beer tastes better than Michelob Ultra, according to Anheuser-Busch Cos., which makes Michelob. Coors decided to pull the ads after Anheuser-Busch filed a challenge with CBS, Anheuser-Busch said. It said the ads were misleading and made "unsubstantiated claims about consumers' taste preference." Viacom Inc.'s CBS and General Electric Co.'
CALIFORNIA | LOCAL
December 7, 2004 |
VISTA A couple who ran an herbal store have agreed to pay $167,000 in fines and reimbursements for improperly acting as physicians and mixing over-the-counter drugs into remedies they sold as herbal, authorities said Monday. Thomas and Linda Hardy reached a settlement with the San Diego County district attorney's office over allegations of false advertising and unfair competition.
October 31, 2004 |
Want to make a deal with the Internal Revenue Service to settle old tax debts for "pennies on the dollar"? You've got plenty of company. Lured by television and radio advertisements that make these deals sound like slam dunks, more than 100,000 taxpayers ask the IRS each year to settle back-tax debts at steep discounts through the agency's "offer-in-compromise" program. Increasingly, the IRS is saying "no."